載入...
Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
Individuals with Down syndrome (DS) are at high risk for developing Alzheimer’s disease (AD) pathology and this has provided significant insights into our understanding of the genetic basis of AD. The present review summarizes recent clinical, neuropathologic, imaging, and fluid biomarker studies of...
Na minha lista:
| 發表在: | CNS Drugs |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395870/ https://ncbi.nlm.nih.gov/pubmed/32506291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-020-00740-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|